World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
24399
World Ranking
14239
National Ranking
591

Aaron D. Schimmer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Aaron D. Schimmer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 531 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Aaron D. Schimmer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Aaron D. Schimmer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Aaron D. Schimmer is affiliated with the Princess Margaret Cancer Centre in Canada. Their research focuses extensively on hematological malignancies, particularly acute myeloid leukemia (AML), as well as broader fields within medicine and molecular biology.

The primary fields of study in their work include Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields such as Molecular Biology, Hematology, Oncology, Genetics, and Public Health, Environmental and Occupational Health.

The main topics of research addressed in their publications cover:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Histone Deacetylase Inhibitors Research
  • Ubiquitin and Proteasome Pathways
  • Protein Degradation and Inhibitors

Aaron D. Schimmer has contributed papers to several frequent publication venues, notably:

  • Blood
  • Cancer Research
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • Haematologica

They have collaborated frequently with several researchers, the most common co-authors being:

  • Mark D. Minden
  • Steven M. Chan
  • Karen Yee
  • Hassan Sibai
  • Andre C. Schuh

Their recent published papers include:

  • Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia, 2022, Signal Transduction and Targeted Therapy
  • Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production, 2021, Blood
  • Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy, 2020, Cell Death and Disease
  • E1 Enzymes as Therapeutic Targets in Cancer, 2020, Pharmacological Reviews
  • Very long chain fatty acid metabolism is required in acute myeloid leukemia, 2021, Blood

Best Publications

  • Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

    Liran I. Shlush;Sasan Zandi;Amanda Mitchell;Weihsu Claire Chen

  • A 17-gene stemness score for rapid determination of risk in acute leukaemia

    Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen

  • Anoikis resistance and tumor metastasis.

    Craig D. Simpson;Craig D. Simpson;Kika Anyiwe;Kika Anyiwe;Aaron D. Schimmer;Aaron D. Schimmer

  • Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

    Aaron D. Schimmer

  • Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia

    Marko Škrtić;Shrivani Sriskanthadevan;Bozhena Jhas;Marinella Gebbia

  • Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

    Aaron D. Schimmer;Kate Welsh;Clemencia Pinilla;Zhiliang Wang

  • Myelodysplastic syndromes: the complexity of stem-cell diseases

    Seth J. Corey;Mark D. Minden;Dwayne L. Barber;Hagop M Kantarjian

  • Targeting XIAP for the treatment of malignancy

    A D Schimmer;S Dalili;S Dalili;R A Batey;S J Riedl

  • Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

    Jo Ishizawa;Sarah F. Zarabi;Sarah F. Zarabi;R. Eric Davis;Ondrej Halgas;Ondrej Halgas

  • Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia

    Alicia Cole;Zezhou Wang;Etienne Coyaud;Veronique Voisin

  • Novel Proteasome Inhibitors to Overcome Bortezomib Resistance

    Amy M. Ruschak;Malik Slassi;Lewis E. Kay;Aaron D. Schimmer

  • Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

    Olga Berezovskaya;Aaron D. Schimmer;Anna B. Glinskii;Clemencia Pinilla

  • AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress

    Shrivani Sriskanthadevan;Danny V. Jeyaraju;Timothy E. Chung;Swayam Prabha

  • The triterpenoid CDDO induces apoptosis in refractory CLL B cells

    Irene M. Pedersen;Shinichi Kitada;Aaron Schimmer;Youngsoo Kim

  • Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

    Jennifer Kouznetsova;Wei Sun;Carles Martínez-Romero;Gregory Tawa

  • Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures

    Anna Y. Lee;Robert P. St.Onge;Michael J. Proctor;Iain M. Wallace

  • A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.

    Aaron D. Schimmer;Susan O'Brien;Hagop Kantarjian;Joseph Brandwein

  • Dysregulation of apoptosis genes in hematopoietic malignancies.

    Shinichi Kitada;Irene M Pedersen;Aaron D Schimmer;John C Reed

  • Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

    Liran I. Shlush;Sasan Zandi;Amanda Mitchell;Weihsu Claire Chen

  • Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures

    A. Y. Lee;R. P. St.Onge;M. J. Proctor;I. M. Wallace

Frequent Co-Authors

Mark D. Minden
Mark D. Minden Princess Margaret Cancer Centre
Vikas Gupta
Vikas Gupta Princess Margaret Cancer Centre
Alessandro Datti
Alessandro Datti University of Perugia
Suzanne Kamel-Reid
Suzanne Kamel-Reid University Health Network
Gary Rodin
Gary Rodin Princess Margaret Cancer Centre
Jeffrey L. Wrana
Jeffrey L. Wrana Lunenfeld-Tanenbaum Research Institute
Camilla Zimmermann
Camilla Zimmermann University of Toronto
Wei Xu
Wei Xu Shenzhen University
Gary D. Bader
Gary D. Bader University of Toronto
David W. Hedley
David W. Hedley Princess Margaret Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to studying Medicine in the USA can open rewarding career pathways in the healthcare sector. Many students seek flexible options that allow for impactful roles without the commitment of a traditional medical doctorate. Online degrees offer flexibility, affordability, and diverse specializations to match your preferred healthcare field.

For those interested in healthcare management, a degree such as the online master of health administration can lead to leadership roles in hospitals, clinics, and health organizations. Some may consider enrolling in online mha programs affordable to obtain high-quality education without overwhelming debt.

Nurses looking to advance their clinical skills may explore cheap dnp online programs, which are designed for those pursuing top nursing roles and specialized positions. Similarly, students interested in pharmaceuticals can further their training through an online pharmd and step into critical patient care and research positions.

Carefully researching accredited and cost-effective online programs can help you find the best fit for your goals.

Best Scientists Citing Aaron D. Schimmer

Trending Scientists

Recently Published Articles